Vertex Pharmaceuticals Inc (NASDAQ:VRTX)

133.20
Delayed Data
As of Apr 24
 -2.62 / -1.93%
Today’s Change
62.41
Today|||52-Week Range
137.50
+12.12%
Year-to-Date

Today’s Trading

Previous close135.82
Today’s open133.61
Day’s range-- - --
Volume1,246,849
Average volume (3 months)1,695,683
Market cap$32.2B
Dividend yield--
Data as of 04/24/2015

Growth & Valuation

Earnings growth (last year)-58.59%
Earnings growth (this year)+52.34%
Earnings growth (next 5 years)+22.00%
Revenue growth (last year)-52.11%
P/E ratioNM
Price/Sales48.16
Price/Book29.96

Competitors

 Today’s
change
Today’s
% change
ALXNAlexion Pharmaceutic...-4.50-2.44%
MYLMylan NV+2.37+3.22%
PRGOPerrigo Company PLC-8.74-4.33%
ZTSZoetis Inc+0.86+1.83%
Data as of 04/24/2015

Financials

Next reporting dateApril 30, 2015
EPS forecast (this quarter)-$0.73
Annual revenue (last year)$580.4M
Annual profit (last year)-$738.6M
Net profit margin-127.09%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Jeffrey M. Leiden
SVP &
GM-International Commercial Operations
Simon Bedson
Corporate headquarters
Boston, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers